Jubilant Pharmova Limited is an integrated pharmaceutical company committed to advancing healthcare and improving patient lives in key markets globally. Operating across six businesses, namely in Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing of sterile injectable, Contract Research Development and Manufacturing, Generics and Proprietary Novel Drugs businesses we hold strong positions in high growth, high-entry-barrier segments and serve global markets through world-class research, manufacturing and commercial capabilities.

We are recognised as a ‘Partner of Choice’ by leading global pharmaceuticals companies, given our ability to combine scientific expertise, customer-centric innovation and disciplined execution to address critical healthcare needs. Backed by an ambitious Vision 2030, we are advancing towards building a resilient platform that is scalable in impact and sustainable in growth.